Cellular and T cell engager Immunotherapy
Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience
Farid Ghamsari, MD
Resident Physician
University of California, San Diego
San Diego, California, United States